Form 4: LeMaitre Vascular CFO Acquires Dividend Equivalent Rights

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

Summary

• On August 29, 2024, Joseph P. Pellegrino JR, the CFO of LeMaitre Vascular Inc. [LMAT], acquired dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and Performance Share Unit (PSU) awards.
• The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to one share of LeMaitre Vascular's common stock.
• The acquisitions include 0.6646 rights related to a 2019 RSU, 1.252 rights related to a 2020 RSU, 2.3821 rights related to a 2021 RSU, 3.6399 rights related to a 2022 RSU, 3.6399 rights related to a 2022 PSU, and 4.1477 rights related to a 2023 RSU.
• Following these transactions, Pellegrino directly owns 18.4793, 26.2423, 36.7272, 33.3082, 32.6252, and 14.3184 dividend equivalent rights respectively.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider activity related to compensation. It doesn't inherently indicate positive or negative performance, but rather transparency.

Positives

• The acquisition of dividend equivalent rights by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. The acquisition of dividend equivalent rights is a common practice related to equity compensation.

Comparison to Industry Standards

• Equity compensation, including RSUs and PSUs with associated dividend equivalent rights, is a standard practice among publicly traded companies, including medical device companies like LeMaitre Vascular.
• Companies such as Medtronic, Boston Scientific, and Abbott also utilize similar equity compensation plans to incentivize and retain key employees.
• The specific terms and amounts of these awards vary based on company size, performance, and individual roles.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders.
• It reflects the company's compensation strategy and alignment of executive interests with shareholder value.

Key Dates